[go: up one dir, main page]

AU3159499A - Antigen preparation and use - Google Patents

Antigen preparation and use

Info

Publication number
AU3159499A
AU3159499A AU31594/99A AU3159499A AU3159499A AU 3159499 A AU3159499 A AU 3159499A AU 31594/99 A AU31594/99 A AU 31594/99A AU 3159499 A AU3159499 A AU 3159499A AU 3159499 A AU3159499 A AU 3159499A
Authority
AU
Australia
Prior art keywords
antigen preparation
antigen
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31594/99A
Inventor
Margaret Anne Stanley
Wei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3159499A publication Critical patent/AU3159499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU31594/99A 1998-03-27 1999-03-29 Antigen preparation and use Abandoned AU3159499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9806666 1998-03-27
GBGB9806666.5A GB9806666D0 (en) 1998-03-27 1998-03-27 Antigen preparation and use
PCT/GB1999/000978 WO1999050424A2 (en) 1998-03-27 1999-03-29 Fusion protein comprising a sequence from a major coat protein of a papovavirus

Publications (1)

Publication Number Publication Date
AU3159499A true AU3159499A (en) 1999-10-18

Family

ID=10829441

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31594/99A Abandoned AU3159499A (en) 1998-03-27 1999-03-29 Antigen preparation and use

Country Status (4)

Country Link
EP (1) EP1066391A2 (en)
AU (1) AU3159499A (en)
GB (1) GB9806666D0 (en)
WO (1) WO1999050424A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1126876B1 (en) 1998-10-16 2007-03-21 GlaxoSmithKline Biologicals S.A. Adjuvant systems and vaccines
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
DE60034947T2 (en) * 1999-06-30 2008-01-24 Evotec Ag VIRUSUAL PARTICLES, PREPARATION AND USE IN SCREENING AND FUNCTIONAL GENOME APPLICATION
DE19952957B4 (en) * 1999-11-03 2006-08-31 Acgt Progenomics Ag Modular transport systems for molecular substances and their preparation and use
CN1114690C (en) * 2001-05-15 2003-07-16 乔良 Papilloma pseudovirus and process for preparing same
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206360D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
EP1523329B1 (en) 2002-07-05 2013-07-24 Folia Biotech Inc. Adjuvant viral particle
GB0228715D0 (en) * 2002-12-09 2003-01-15 Glaxosmithkline Biolog Sa Vaccine
US7858098B2 (en) 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
US7758866B2 (en) 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
EP1877087B1 (en) 2005-04-15 2013-02-20 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
DE102006041970A1 (en) * 2006-08-28 2008-03-06 Genome Identification Diagnostics Gmbh Method and means for detecting human papillomavirus
CZ301144B6 (en) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Preparation of monoclonal antibodies against FoxP3 protein using modified virus resembling particles of Mason-Pfizer ape virus
EP2377879A1 (en) * 2010-04-14 2011-10-19 Deutsches Krebsforschungszentrum N-terminal HPV E7 fusion proteins
IL271461B2 (en) 2017-06-23 2023-09-01 Pathovax Llc Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
CN113396155A (en) 2018-12-27 2021-09-14 维伊木恩股份有限公司 Conjugated virus-like particles and their use as anti-tumor immune redirection agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9106105U1 (en) * 1991-05-17 1991-09-26 Behringwerke Ag, 3550 Marburg Diagnostic kit for the detection of human papillomavirus infections
AUPM358894A0 (en) * 1994-01-31 1994-02-24 Csl Limited Modified papilloma virus l2 protein and vlps formed therefrom
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
DE19526752C2 (en) * 1995-07-21 1997-08-07 Lutz Prof Dr Gissmann Highly efficient formation of particles similar to papillomavirus
PT809700E (en) * 1994-10-07 2006-09-29 Univ Loyola Chicago PARTICLES SIMILAR TO PAPILLOMAVIRUS AND FUSEOUS PROTEINS, AND METHODS FOR THEIR PRODUCTION
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use

Also Published As

Publication number Publication date
WO1999050424A3 (en) 1999-12-02
WO1999050424A2 (en) 1999-10-07
EP1066391A2 (en) 2001-01-10
GB9806666D0 (en) 1998-05-27

Similar Documents

Publication Publication Date Title
AU4161899A (en) Radiotherapeutical device and use thereof
AU6503299A (en) High-beta-conglycinin products and their use
AU6325599A (en) New compounds, their preparation and use
AU6325899A (en) New compounds, their preparation and use
AU6190199A (en) New compounds, their preparation and use
AU6190299A (en) New compounds, their preparation and use
AU9790198A (en) Compounds and methods
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
ZA982478B (en) Compounds their use and preparation
AU3159499A (en) Antigen preparation and use
AU9781998A (en) Huchordin and uses thereof
AU1926000A (en) Pth1r and pth3r receptors
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU7401598A (en) Epoxide-amine dendrimers and the preparation and use thereof
AU7095296A (en) Phosphorylamides, their preparation and use
AU3595099A (en) New compounds, their preparation and use
AU6351199A (en) Pectins and the preparation thereof
CZ20011896A3 (en) Immunogenic preparation and antibody
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AUPP363498A0 (en) Antigens and their detection
AU5557698A (en) Novel calpaines, their preparation and use
PL328334A1 (en) Preparation and application thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase